The prognostic value of cardiac troponin for 60 day mortality and major adverse events in COVID-19 patients

BACKGROUND: The variability of coronavirus disease 2019 (COVID-19) illness severity has puzzled clinicians and has sparked efforts to better predict who would benefit from rapid intervention. One promising biomarker for in-hospital morbidity and mortality is cardiac troponin (cTn). METHODS: A retros...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruge, Max, Gomez, Joanne Michelle D., du Fay de Lavallaz, Jeanne, Hlepas, Alexander, Rahman, Annas, Patel, Priya, Lavani, Prutha, Nair, Gatha G., Jahan, Nusrat, Simmons, J. Alan, Rao, Anupama K, Williams, Kim A., Volgman, Annabelle Santos, Marinescu, Karolina, Suboc, Tisha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330143/
https://www.ncbi.nlm.nih.gov/pubmed/34358679
http://dx.doi.org/10.1016/j.carpath.2021.107374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330143/
https://www.ncbi.nlm.nih.gov/pubmed/34358679
http://dx.doi.org/10.1016/j.carpath.2021.107374

Ejemplares similares